HH Clinical Consulting Limited 10690397 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is specialists medical and phycological practice activities Digita Accounts Production Advanced 6.30.9574.0 true true 10690397 2023-04-01 2024-03-31 10690397 2024-03-31 10690397 core:CurrentFinancialInstruments 2024-03-31 10690397 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 10690397 core:FurnitureFittingsToolsEquipment 2024-03-31 10690397 bus:SmallEntities 2023-04-01 2024-03-31 10690397 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 10690397 bus:FullAccounts 2023-04-01 2024-03-31 10690397 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 10690397 bus:RegisteredOffice 2023-04-01 2024-03-31 10690397 bus:Director1 2023-04-01 2024-03-31 10690397 bus:Director2 2023-04-01 2024-03-31 10690397 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10690397 core:ComputerEquipment 2023-04-01 2024-03-31 10690397 core:FurnitureFittings 2023-04-01 2024-03-31 10690397 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 10690397 countries:UnitedKingdom 2023-04-01 2024-03-31 10690397 2023-03-31 10690397 core:FurnitureFittingsToolsEquipment 2023-03-31 10690397 2022-04-01 2023-03-31 10690397 2023-03-31 10690397 core:CurrentFinancialInstruments 2023-03-31 10690397 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 10690397 core:FurnitureFittingsToolsEquipment 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 10690397

HH Clinical Consulting Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

 

HH Clinical Consulting Limited

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 5

 

HH Clinical Consulting Limited

(Registration number: 10690397)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

5

2,643

2,006

Current assets

 

Debtors

6

-

222

Cash at bank and in hand

 

15,757

5,644

 

15,757

5,866

Creditors: Amounts falling due within one year

7

(9,372)

(7,178)

Net current assets/(liabilities)

 

6,385

(1,312)

Total assets less current liabilities

 

9,028

694

Provisions for liabilities

(502)

(381)

Net assets

 

8,526

313

Capital and reserves

 

Called up share capital

2

2

Retained earnings

8,524

311

Shareholders' funds

 

8,526

313

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 12 August 2024 and signed on its behalf by:
 

Dr C J Hammond
Director

Dr K M Hinsby
Director

 
     
 

HH Clinical Consulting Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Parkhill Studio
Walton Road
Wetherby
West Yorkshire
LS22 5DZ
England

These financial statements were authorised for issue by the Board on 12 August 2024.

2

Accounting policies

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

HH Clinical Consulting Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

33% straight line

Fixtures and fittings

33% straight line

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

4

Profit before tax

Arrived at after charging/(crediting)

2024
£

2023
£

Depreciation expense

2,028

1,940

 

HH Clinical Consulting Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

5

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2023

7,632

7,632

Additions

2,665

2,665

Disposals

(4,210)

(4,210)

At 31 March 2024

6,087

6,087

Depreciation

At 1 April 2023

5,626

5,626

Charge for the year

2,028

2,028

Eliminated on disposal

(4,210)

(4,210)

At 31 March 2024

3,444

3,444

Carrying amount

At 31 March 2024

2,643

2,643

At 31 March 2023

2,006

2,006

6

Debtors

Current

2024
£

2023
£

Prepayments

-

222

 

-

222

7

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

8

7,008

6,945

Trade creditors

 

90

90

Taxation and social security

 

2,274

143

 

9,372

7,178

 

HH Clinical Consulting Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

8

Loans and borrowings

Current loans and borrowings

2024
£

2023
£

Other borrowings

7,008

6,945